Armata Pharmaceuticals (ARMP) Enterprise Value (QoQ) (2013 - 2026)

Armata Pharmaceuticals (ARMP) Enterprise Value (QoQ) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Armata Pharmaceuticals 174.25 Mn 169.45 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 44.75%
Dec 31, 2025 41.12%
Sep 30, 2025 -240.94%
Jun 30, 2025 62.97%
Mar 31, 2025 -25.80%
Dec 31, 2024 45.80%
Sep 30, 2024 35.08%
Jun 30, 2024 30.26%
Mar 31, 2024 -179.97%
Dec 31, 2023 43.56%
Sep 30, 2023 -92.34%
Jun 30, 2023 50.39%
Mar 31, 2023 -69.04%
Dec 31, 2022 41.49%
Sep 30, 2022 31.36%
Jun 30, 2022 20.32%
Mar 31, 2022 -351.09%
Dec 31, 2021 14.81%
Sep 30, 2021 31.14%
Jun 30, 2021 21.91%